Arkolith/Insider Trading/SYRS/Form 4

Akkaraju Srinivas

DirectorSyros Pharmaceuticals, Inc. (SYRS) · full profile →Form 4 · filed Dec 26, 2023
Net Buying
Open-Market Buys
$4.0M
Open-Market Sells
$0
Net Open-Market Flow
$4.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 21, 2023Buy(P)905K$4.42$4.0M1.8M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-059693) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML